Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

EXOSC3 anticorps (AA 2-275)

EXOSC3 Reactivité: Humain ELISA, IHC Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN7152285
  • Antigène Voir toutes EXOSC3 Anticorps
    EXOSC3 (Exosome Component 3 (EXOSC3))
    Épitope
    • 5
    • 5
    • 4
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 2-275
    Reactivité
    • 31
    • 10
    • 7
    • 7
    • 7
    • 7
    • 7
    • 6
    • 4
    • 4
    • 2
    • 2
    • 2
    • 1
    • 1
    Humain
    Hôte
    • 24
    • 7
    Lapin
    Clonalité
    • 26
    • 5
    Polyclonal
    Conjugué
    • 21
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp EXOSC3 est non-conjugé
    Application
    • 20
    • 8
    • 7
    • 5
    • 5
    • 3
    • 1
    • 1
    ELISA, Immunohistochemistry (IHC)
     Réactivité croisée
    Humain
    Purification
    >95%, Protein G purified
    Immunogène
    Recombinant Human Exosome complex component RRP40 protein (2-275AA)
    Isotype
    IgG
    Top Product
    Discover our top product EXOSC3 Anticorps primaire
  • Indications d'application
    Recommended dilution: IHC:1:20-1:200,
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4
    Agent conservateur
    ProClin
    Précaution d'utilisation
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    -20 °C,-80 °C
    Stockage commentaire
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Antigène
    EXOSC3 (Exosome Component 3 (EXOSC3))
    Autre désignation
    EXOSC3 (EXOSC3 Produits)
    Synonymes
    anticorps PCH1B, anticorps RP11-3J10.8, anticorps RRP40, anticorps Rrp40p, anticorps bA3J10.7, anticorps hRrp-40, anticorps p10, anticorps 2310005D06Rik, anticorps AI593501, anticorps Rrp40, anticorps im:7140537, anticorps zgc:112345, anticorps exosome component 3, anticorps exosome component 3 L homeolog, anticorps EXOSC3, anticorps exosc3.L, anticorps Exosc3, anticorps exosc3
    Sujet

    Background: Non-catalytic component of the RNA exosome complex which has 3\'->5\' exoribonuclease activity and participates in a multitude of cellular RNA processing and degradation events. In the nucleus, the RNA exosome complex is involved in proper maturation of stable RNA species such as rRNA, snRNA and snoRNA, in the elimination of RNA processing by-products and non-coding \'pervasive\' transcripts, such as antisense RNA species and promoter-upstream transcripts (PROMPTs), and of mRNAs with processing defects, thereby limiting or excluding their export to the cytoplasm. The RNA exosome may be involved in Ig class switch recombination (CSR) and/or Ig variable region somatic hypermutation (SHM) by targeting AICDA deamination activity to transcribed dsDNA substrates. In the cytoplasm, the RNA exosome complex is involved in general mRNA turnover and specifically degrades inherently unstable mRNAs containing AU-rich elements (AREs) within their 3\' untranslated regions, and in RNA surveillance pathways, preventing translation of aberrant mRNAs. It seems to be involved in degradation of histone mRNA. The catalytic inactive RNA exosome core complex of 9 subunits (Exo-9) is proposed to play a pivotal role in the binding and presentation of RNA for ribonucleolysis, and to serve as a scaffold for the association with catalytic subunits and accessory proteins or complexes. EXOSC3 as peripheral part of the Exo-9 complex stabilizes the hexameric ring of RNase PH-domain subunits through contacts with EXOSC9 and EXOSC5.

    Aliases: EXOSC3 antibody, RRP40 antibody, CGI-102Exosome complex component RRP40 antibody, Exosome component 3 antibody, Ribosomal RNA-processing protein 40 antibody, p10 antibody

    UniProt
    Q9NQT5
    Pathways
    Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, SARS-CoV-2 Protein Interactome
Vous êtes ici: